# Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy

> **NCT07434492** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Shirley Ryan AbilityLab** · enrollment: 60 (estimated)

## Conditions studied

- Cerebral Palsy

## Interventions

- **DEVICE:** Smart Ankle-Foot Orthosis
- **DRUG:** 5-Azacitidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07434492
- **Lead sponsor:** Shirley Ryan AbilityLab
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2030-08-31
- **Final completion:** 2030-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07434492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07434492, "Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07434492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*